PRODUCTS

More Reyra operates across three business verticals: API, Finished Formulations, and Contract Research and Manufacturing.

We collaborate with global pharmaceutical companies to produce fermentation and semi-synthetic complex niche APIs in the fields of Immunosuppressants, Oncology, Antibacterials, and Antifungals.

At More Reyra, quality is our top priority. We adhere to a “one product-one process” philosophy for global markets, ensuring consistency and reliability. This approach underpins our global DMF filings. More Reyra is recognized as a trusted and reliable supplier of APIs that meet international regulatory standards.

Understanding and meeting client needs within defined timelines is crucial to More Reyra’s success. Over the years, More Reyra has launched numerous products and maintains a robust product pipeline.

More Reyra has also developed and commercialized a portfolio of complex and challenging formulations for global markets. The company sells its products in the USA and other international markets, offering oral solids (tablets and capsules), oral liquids, and suspensions across therapeutic segments such as Immunosuppressants, Nephrology drugs, and critical care Anti-infectives.

Leveraging its core competencies in fermentation and semi-synthesis APIs, along with the development of complex formulations, More Reyra provides end-to-end services from conceptualization to commercialization as part of its Contract Research and Manufacturing business. Currently, More Reyra is working on several new chemical entities (NCEs) and generic products, focusing on strain improvement, media optimization, process scale-up from R&D to pilot and commercial stages, and the development of complex formulations.

API

CONTRACT RESEARCH & MANUFACTURING

PRODUCTS

More Reyra offers contract research and manufacturing services specializing in fermentation and semi-synthetic new chemical entities (NCEs) and small molecules.

More Reyra boasts one of the world’s most extensive portfolios of complex fermentation and semi-synthetic APIs.

FORMULATION

CONTRACT RESEARCH & MANUFACTURING

EMERGING MERKETS

REGULATED MARKETS

More Reyra offers formulation development and contract manufacturing services.

More Reyra has a global presence for its finished formulations.

More Reyra produces and supplies specialized formulations to the U.S. market.

INDIA FORMULATION

NEPHROLOGY

CRITICAL CARE

More Reyra is a fully integrated company that manufactures immunosuppressant formulations and supplies CKD and nephrology products under its own brand.

More Reyra is dedicated to delivering high-quality products in the Critical Care segment with a patient-centric approach aimed at saving lives.

PRODUCTS